Pharma CEOs Plugged In To Medicare
Executive Summary
Below are excerpts from remarks on Medicare Part D made by executives at the Jan. 4-5 Morgan Stanley Pharmaceutical CEOs Unplugged conference in New York. Most CEOs are sticking with conservative forecasts for now that Medicare will have at most a modest impact on their business. While Merck and GlaxoSmithKline did not mention Medicare in their presentations, Pfizer devoted most of its talk to Part D, reporting that it is "retooling" to take advantage of Medicare opportunities.